Charities

For Shareholders

Information on this website is directed at persons who are shareholders in BACIT Limited and is provided for their exclusive use and benefit. Users are responsible for observing all applicable laws and regulations in their relevant jurisdictions before proceeding.

BACIT Limited operates as a closed-ended investment company dedicated to channelling capital toward the battle against cancer. Its charitable purpose is woven directly into its investment mandate, with the fund structured so that a meaningful portion of its returns can be directed toward organisations working on cancer research, treatment, and patient support. By aligning financial performance with philanthropic outcomes, the company offers shareholders a way to participate in markets while contributing to a wider social mission. The emphasis is on long-term stewardship, disciplined portfolio construction, and transparency in how investment income is ultimately shared with charitable partners operating in the field of oncology and related areas of care and research across multiple jurisdictions.

Charities and foundations considering a relationship with BACIT benefit from an arrangement that bridges institutional investment management and structured giving. The fund invests in a diversified range of public securities, aiming to grow capital over time so that distributions can be made on a sustainable basis. This approach allows recipient organisations to plan with greater confidence, knowing that the underlying vehicle is governed by recognised fund management standards and overseen by a board with fiduciary responsibility. The model recognises that long-term progress against cancer requires predictable, well-managed funding streams, and it offers charities an institutional counterparty whose interests are explicitly aligned with theirs through the company's founding objectives and ongoing governance framework.

For potential charity partners, the on-ramp to engagement typically begins with a review of the fund's published objectives, historical distributions, and stated areas of charitable focus. Interested organisations are generally encouraged to assess whether their mission aligns with the company's cancer-related remit and to engage with the appropriate representatives in due course. Once a fit is established, discussions can cover the scale and timing of any future support, reporting expectations, and how the contribution might be deployed within specific research programmes, patient services, or awareness initiatives. Throughout this process, the underlying principle remains the same: charitable distributions should be made in a way that is sustainable for the fund, meaningful for the recipient, and consistent with applicable laws and regulatory expectations.

Shareholders and observers alike can track the company's charitable activity through its periodic reporting, which describes how investment performance translates into support for the wider cancer community. The combination of a closed-ended fund structure, a defined beneficiary base, and a long-term investment horizon distinguishes BACIT from conventional grant-making bodies, giving it a hybrid character that sits between the financial and philanthropic sectors. Over time, the intent is for this model to demonstrate that capital markets can be harnessed not only for return, but also for measurable social impact, helping to sustain the organisations and researchers who carry forward the day-to-day work of improving outcomes for those affected by cancer in many different forms and at many different stages of the patient journey.